Related Experiment Video
Updated: Jul 3, 2026
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Chronic nicotine exposure has dissociable behavioural effects on control and beta2-/- mice
Morgane Besson1, Sandra Suarez, Anne Cormier
1Unité Neurobiologie Intégrative des Systèmes Cholinergiques, Department of Neuroscience and CNRS URA2182, Institut Pasteur, 25 rue du Dr. Roux, Paris 75015, France.
Abstract:
Nicotine exerts beneficial effects on various neurological and psychiatric pathologies, yet its effects on cognitive performance remain unclear. Mice lacking the beta2 subunit of the nicotinic receptor (beta2-/-) show characteristic deficits in executive functions and are suggested as reliable animal models for some specific endophenotypes of human pathologies, notably ADHD. We use beta2-/- and their controls to investigate the consequences of chronic nicotine exposure on cognitive behaviour. We show that in control mice, this treatment elicits somewhat slight effects, particularly affecting nocturnal activity and self-grooming. By contrast, in beta2-/- mice, chronic nicotine treatment had restorative effects on exploratory behaviour in the open-field and affected rearing, but did not modify motor functions. We confirmed that beta2-/- mice exhibit impaired exploratory and social behaviour, and further demonstrated their nocturnal hyperactivity. These data support the proposal that beta2-/- mice represent a relevant model for cognitive disorders in humans and that nicotine administered chronically at low dose may relieve some of these.
Insights
Nicotine may help restore cognitive functions in mice lacking the beta2 subunit of the nicotinic receptor (beta2-/-), a model for attention deficit hyperactivity disorder (ADHD). This suggests potential therapeutic benefits for related human cognitive disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Nicotine's effects on cognitive performance are not fully understood.
- Mice lacking the beta2 nicotinic receptor subunit (beta2-/-) exhibit executive function deficits, modeling human attention deficit hyperactivity disorder (ADHD).
Purpose of the Study:
- To investigate the impact of chronic nicotine exposure on cognitive behavior in beta2-/- mice and their controls.
- To evaluate the therapeutic potential of low-dose nicotine in a mouse model of cognitive disorders.
Main Methods:
- Chronic nicotine administration to beta2-/- mice and control littermates.
- Assessment of cognitive behaviors including exploratory activity, motor function, and social interaction.
- Behavioral testing in open-field and other relevant paradigms.
Main Results:
- In control mice, nicotine caused minor changes in activity and grooming.
- In beta2-/- mice, nicotine improved exploratory behavior and rearing without altering motor function.
- Beta2-/- mice displayed impaired exploratory and social behavior, alongside nocturnal hyperactivity.
Conclusions:
- Beta2-/- mice serve as a valid model for human cognitive disorders.
- Chronic low-dose nicotine administration may alleviate specific cognitive deficits observed in beta2-/- mice.
- Findings support nicotine's potential as a therapeutic agent for certain cognitive impairments.
